At first step, the expression of TRAIL, DKK-3 and chemokines including CXCR-4 and CCR-4 were analyzed in AD-MSCs after activation with TNF-α, IFN-γ and TNF-α plus IFN-γ in different doses (data not shown). This evidence concerns the gene DKK3 and Alzheimer disease.